3Ginsverg MD, pulsinelli WA. The isehemie penumba injury thresholds, and the therapeutic window for acute stroke[J]. Ann Nearol,1994,36(4) :553-554
4Wise RJ, Bernardi S, Frackowiak RS, et al. Serial observations on the pathophysiology of acute stroke. The transition from ischaemia to infarction as reflected in regional oxygen extraction[J]. Brain, 1983,106(Pt 1) : 197-201
5Mori E, Tabuehi M, Yoshida T, et al. Intracatotid urokinase with thromboembolie occlusion of the middle eerbral artery [ J ]. Stroke,1998,19(7) :802-812
3[1]Hantson L,Deweerdt W,De keyser J,et al. The European Stroke Scale[J]. Stroke,1994,25:2215-2219.
4[2]Memezawa H,Simith ML,Siesjo BK. Penumbral tissue salvaged by reperfusion following middle cerebral artery occlusion in rats[J]. Stroke,1992,23:552-567.
5[3]Del Zoppo GJ,Pessin MS,Mori E,et al. Thrombolytic intervention in acute thrombolic and embolic stroke[J]. Semin Neurol,1991,11:368-384.
6[4]The ECASS Study Grroup. Intravenous thrombolysis with recombinant tissue plasminogcn activator for acute hemispheric stroke[J]. JAMA,1995,274:1017-1025.
7[5]The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke[J]. N Engl J Med,1995,333:1581-1592.
8[6]Multicenter Acute Stroke Trial-Italy (MAST-I) Group. Randomised controlled trial of streptokinase,aspirin and combination of both in treatment of acute ischemic stroke[J]. Lancet,1995,346:1509-1514.
9[3]Russel D,Madden KP,Clark WM,et al.Tissue plasminogen activator cerebrovascular thrombolysis in rabbits is dependent on the rate and route of administration.Stroke,1992,23:388~393